Dr. Squatch, the #1 natural men’s personal care brand in the U.S., has cast Megan Fox as the face of its boldest campaign yet. She stars as Professor Fox, Head Professor at the fictional Foundation for Odor Excellence (a.k.a. The F.O.X.), where she’s on a mission to school men on what’s actually inside their deodorant.
The campaign, announced on April 15, 2026, rolls out as a six part creative series across Dr. Squatch‘s owned channels, including organic and paid social, and is built around the launch of two new products: Invisible Glide and Spray Deodorant, both priced at $13.00 and available at drsquatch.com, Amazon, Target, Walmart, Kroger, CVS, Walgreens, and H-E-B.
Six Lessons, One Very Specific Goal
The campaign unfolds like a curriculum, each installment set inside The F.O.X., from the classroom to the lab to the dating scene. Professor Fox breaks down the synthetic ingredient list hiding in conventional…
deodorants. Megan Fox said, “There are a lot of smelly, low-performing sticks out there, and what’s inside them is even worse: synthetic ingredients that have no business being on a human body. The good news is that Dr.
Squatch‘s deodorant is made with over 98% natural ingredients, and built around scents worth bragging about.” Two New Products at the Center of It All The Invisible Glide is a clear, aluminum free formula made with 98% natural origin ingredients that delivers all day odor protection with no residue and no white marks on shirts.
The Spray Deodorant offers up to 72 hours of odor protection in a butane free, 360 degree formula that dries in seconds. Both products are a direct answer to what Dr. Squatch sees as a long overdue gap in the men’s grooming aisle. John Ludeke, Chief Brand Officer at Dr.
Squatch, said that “The men’s deodorant aisle has been coasting for decades, and guys have been paying the price with unnatural, synthetic ingredients, and scents reminiscent of a 2004 middle school locker room. Who better to get men to listen than Megan Fox?” Why the Campaign Works Dr…
Discussion
0 Comments
No comments yet
Start the conversation
Share your take on this story and help shape the discussion.
Sign in to join the discussion.